Skip to main content

Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study.

Publication ,  Journal Article
Wei, J; Jiang, H; Zeng, M; Wang, M; Niu, M; Gu, D; Chong, H; Zhang, Y; Fu, F; Zhou, M; Chen, J; Lyv, F; Wei, H; Bashir, MR; Song, B; Li, H; Tian, J
Published in: Cancers (Basel)
May 14, 2021

Microvascular invasion (MVI) is a critical risk factor for postoperative recurrence of hepatocellular carcinoma (HCC). Preknowledge of MVI would assist tailored surgery planning in HCC management. In this multicenter study, we aimed to explore the validity of deep learning (DL) in MVI prediction using two imaging modalities-contrast-enhanced computed tomography (CE-CT) and gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI). A total of 750 HCCs were enrolled from five Chinese tertiary hospitals. Retrospective CE-CT (n = 306, collected between March, 2013 and July, 2019) and EOB-MRI (n = 329, collected between March, 2012 and March, 2019) data were used to train two DL models, respectively. Prospective external validation (n = 115, collected between July, 2015 and February, 2018) was performed to assess the developed models. Furthermore, DL-based attention maps were utilized to visualize high-risk MVI regions. Our findings revealed that the EOB-MRI-based DL model achieved superior prediction outcome to the CE-CT-based DL model (area under receiver operating characteristics curve (AUC): 0.812 vs. 0.736, p = 0.038; sensitivity: 70.4% vs. 57.4%, p = 0.015; specificity: 80.3% vs. 86.9%, p = 0.052). DL attention maps could visualize peritumoral high-risk areas with genuine histopathologic confirmation. Both DL models could stratify high and low-risk groups regarding progression free survival and overall survival (p < 0.05). Thus, DL can be an efficient tool for MVI prediction, and EOB-MRI was proven to be the modality with advantage for MVI assessment than CE-CT.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancers (Basel)

DOI

ISSN

2072-6694

Publication Date

May 14, 2021

Volume

13

Issue

10

Location

Switzerland

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wei, J., Jiang, H., Zeng, M., Wang, M., Niu, M., Gu, D., … Tian, J. (2021). Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study. Cancers (Basel), 13(10). https://doi.org/10.3390/cancers13102368
Wei, Jingwei, Hanyu Jiang, Mengsu Zeng, Meiyun Wang, Meng Niu, Dongsheng Gu, Huanhuan Chong, et al. “Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study.Cancers (Basel) 13, no. 10 (May 14, 2021). https://doi.org/10.3390/cancers13102368.
Wei J, Jiang H, Zeng M, Wang M, Niu M, Gu D, et al. Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study. Cancers (Basel). 2021 May 14;13(10).
Wei, Jingwei, et al. “Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study.Cancers (Basel), vol. 13, no. 10, May 2021. Pubmed, doi:10.3390/cancers13102368.
Wei J, Jiang H, Zeng M, Wang M, Niu M, Gu D, Chong H, Zhang Y, Fu F, Zhou M, Chen J, Lyv F, Wei H, Bashir MR, Song B, Li H, Tian J. Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study. Cancers (Basel). 2021 May 14;13(10).

Published In

Cancers (Basel)

DOI

ISSN

2072-6694

Publication Date

May 14, 2021

Volume

13

Issue

10

Location

Switzerland

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis